查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2054975

鎮痛藥市場：依藥物類別、適應症、劑型、活性成分、性別、類型、年齡層、給藥途徑、分銷管道和地區分類

Analgesics Market, By Drug Class, By Indication, By Dosage Form, By Drug Composition, By Availability, By Type, By Gender, By Age Group, By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球止痛藥市場預計2026年達到583億美元，預計2033年將達到929.9億美元。預計從2026年到2033年，該市場將以6.9%的複合年成長率成長。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 583億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 6.90% 2033年市場規模預測： 929.9億美元

全球鎮痛藥市場的成長主要受慢性及急性疼痛疾病在全球日益普遍的推動。鎮痛藥在緩解疼痛、改善患者生活品質方面發揮著至關重要的作用。生活方式的改變和壓力水平的上升導致多種疼痛相關疾病顯著增加，包括腰痛、關節炎和偏頭痛。藥物傳遞和製劑研發技術的進步推動了對更有效、成癮風險更低的新型止痛藥的需求。此外，老年人口的增加，尤其是易患骨關節炎和肌肉骨骼疾病的老年族群，也是推動鎮痛藥需求成長的因素之一。然而，圍繞鴉片類藥物的嚴格監管以及替代療法的開發，可能會給行業相關人員帶來挑戰。

市場動態

全球鎮痛藥市場成長的主要驅動力是各種疼痛相關慢性疾病（包括關節炎、背痛、偏頭痛和骨質疏鬆症）盛行率的上升，而這又與全球人口老化密切相關。據估計，到2030年，全球超過20%的人口將患有骨關節炎。久坐不動的工作方式和日益成長的壓力水平等生活方式改變顯著增加了肌肉骨骼疾病的發病率，從而推動了對鎮痛藥的需求。然而，人們對處方類鴉片藥物濫用和誤用的日益擔憂可能會阻礙市場成長。這促使監管機構收緊了對鴉片類鎮痛藥核准和使用的監管。此外，大麻素、針灸和物理治療等替代療法的日益普及可能會抑制對傳統鎮痛藥的需求。針對慢性疼痛管理的有利保險報銷政策為鎮痛藥生產商提供了盈利空間。對開發非成癮性配方和先進藥物輸送系統的持續研究可能會帶來未來的成長機會。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
  • 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球鎮痛藥市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
  • 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球止痛藥市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以利用各種用於分析全球止痛藥市場的策略矩陣，更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管趨勢
  • 收購與合作趨勢
  • 資金籌措及投資
  • PEST分析
  • 波特的分析

第4章 全球鎮痛藥市場：依藥物類別分類，2021-2033年

  • 概述
  • 組合藥物止痛藥（包括含有麻醉性止痛藥的組合藥物止痛藥）
  • 偏頭痛藥物
  • 複合抑制劑
  • 對乙醯胺酚和其他止痛藥
  • 麻醉性止痛藥
  • 非類固醇消炎劑（NSAIDs）

第5章 全球鎮痛藥市場：依適應症分類，2021-2033年

  • 概述
  • 偏頭痛
  • 頭痛和叢集性頭痛
  • 過敏性鼻炎
  • 焦慮
  • 腰痛
  • 感冒症狀
  • 發燒
  • 宿醉
  • 流感
  • 失眠
  • 肌肉酸痛
  • 骨關節炎
  • 疼痛
  • 疼痛和發燒
  • 月經疼痛
  • 術後疼痛
  • 月經症候群
  • 月經症候群
  • 類風濕性關節炎
  • 鼻竇炎
  • 僵直性脊椎炎
  • 慢性疼痛
  • 遺傳性腺瘤性息肉症
  • 高血壓
  • 幼年類風濕性關節炎
  • 脊椎關節炎
  • 小腦扁桃體下疝氣畸形
  • 耳咽管功能障礙
  • 頸部疼痛
  • 足底筋膜炎
  • 坐骨神經痛
  • 橫貫性脊髓炎
  • 咳嗽
  • 鴉片類藥物使用障礙
  • 無菌性壞死
  • 巴特氏症候群
  • 黏液囊炎
  • 慢性肌筋膜疼痛
  • 肋軟骨炎
  • 瀰漫性特發性性骨發育不良
  • 自主神經系統功能障礙
  • 凍肩
  • 急性痛風
  • 發炎性疾病
  • 預防非類固醇抗發炎藥引起的潰瘍
  • 開放性動脈導管
  • 多發性肌痛
  • 神經根病
  • 椎間滑脫
  • 顳顎關節障礙
  • 肌腱炎
  • 牙痛
  • 美容支持
  • 突發性疼痛
  • 糖尿病周邊神經病變
  • 腹瀉
  • 分娩疼痛
  • 輕度鎮靜
  • 新生兒戒斷症候群
  • 鴉片類成癮－誘導
  • 鴉片類藥物成癮－維持治療
  • 鴉片類藥物戒斷
  • 鎮靜
  • 心絞痛
  • 預防心絞痛
  • 抗磷脂症候群
  • 氣體
  • 心臟病發作
  • 消化不良
  • 缺血性中風
  • 缺血性中風預防
  • 菸鹼酸潮紅
  • 心肌梗塞預防
  • 菸鹼酸潮紅
  • 預防心房顫動患者的血栓性栓塞症栓塞
  • 人工心臟瓣膜－血栓症預防
  • 人工心臟瓣膜、機械瓣膜－血栓症預防
  • 重組手術，預防
  • 風濕熱
  • 預防血栓栓塞性中風
  • 短暫性腦缺血發作（TIA）
  • 其他

第6章 全球鎮痛藥市場：依劑型分類，2021-2033年

  • 概述
  • 藥片
  • 膠囊
  • 注射藥物
  • 修補
  • 滾珠式
  • 噴
  • 乳膏、凝膠、軟膏
  • 其他（栓劑、鼻噴劑等）

第7章 全球鎮痛藥市場：依藥物成分分類，2021-2033年

  • 概述
  • 單身的
  • 組合

第8章 全球鎮痛藥市場：依性別分類的供應情況，2021-2033年

  • 概述
  • OTC
  • 處方藥

第9章 全球止痛藥市場：依類型分類，2021-2033年

  • 概述
  • 品牌
  • 學名藥

第10章 全球止痛藥市場：依性別分類，2021-2033年

  • 概述
  • 男性
  • 女士

第11章 全球止痛藥市場：依年齡層別分類，2021-2033年

  • 概述
  • 兒童和嬰兒
  • 孩子們
  • 成人
  • 老年人

第12章 全球鎮痛藥市場：依通路分類，2021-2033年

  • 概述
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第13章 全球止痛藥市場：依年齡層別分類，2021-2033年

  • 概述
  • 兒童和嬰兒
  • 孩子們
  • 成人

第14章 全球鎮痛藥市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第15章 競爭格局

  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Merck & Co., Inc.
    • AstraZeneca
    • Johnson & Johnson Private Limited
    • Hikma Pharmaceuticals PLC
    • Dr. Reddy's Laboratories Ltd.
    • Fresenius Kabi AG
    • Aurobindo Pharma
    • Bausch Health Companies Inc.
    • Amneal Pharmaceuticals LLC.
    • Apotex Inc.
    • Eli Lilly and Company
    • Cipla Inc.
    • Lupin

第16章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第17章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI7207

Global Analgesics Market is estimated to be valued at USD 58.30 Bn in 2026 and is expected to reach USD 92.99 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 58.30 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.90% 2033 Value Projection: USD 92.99 Bn

Global analgesics market growth is driven by rising prevalence of chronic and acute pain disorders worldwide. Analgesics drugs play a crucial role in relieving pain and enhancing the quality of life of patients. Changing lifestyles and higher stress levels have significantly increased several pain-related ailments like backache, arthritis, and migraines among others. Technological advancements in drug delivery systems and formulation development have boosted demand for novel analgesic medications with improved efficacy and reduced risk of addiction. Moreover, growing geriatric population prone to osteoarthritis and musculoskeletal disorders can also boost demand for analgesics. However, strict regulations surrounding opioid medications and development of alternative therapies can pose challenges to industry players.

Market Dynamics

Global analgesics market growth is primarily driven by rising prevalence of various pain-related chronic conditions like arthritis, back pain, migraines, and osteoporosis due to growing geriatric population worldwide. As per estimates, over 20% of the global population will suffer from osteoarthritis by 2030. Changing lifestyles with sedentary jobs and increased stress levels have substantially raised the incidence of musculosketal disorders, thus, boosting demand for analgesic. However, growing concerns over misuse and abuse of prescription opioids can hamper the market growth. This has led regulatory bodies to tighten rules surrounding opioid analgesic approvals and usage. Moreover, alternative therapies like cannabinoid-based drugs, acupuncture, and physiotherapy are gaining popularity, and this can hamper demand for traditional painkillers. Favorable reimbursement policies for chronic pain management provides profitable opportunities for analgesic manufacturers. Ongoing research towards develop non-addictive formulas and advanced drug delivery systems can offer growth opportunities in the future.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global analgesics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Aurobindo Pharma, Bausch Health Companies Inc., Amneal Pharmaceuticals LLC., Apotex Inc., Eli Lilly and Company, Cipla Inc., Lupin
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global analgesics market

Market Segmentation

  • By Drug Class (Revenue, USD Bn, 2021 - 2033)
  • Analgesic Combinations (Includes Narcotic Analgesic Combinations)
    • Acetaminophen + Aspirin
    • Acetaminophen + Aspirin + Caffeine
    • Acetaminophen + Butalbital
    • Acetaminophen + Butalbital + Caffeine
    • Acetaminophen + Caffeine
    • Acetaminophen +Caffeine + Isometheptene Mucate
    • Acetaminophen + Caffeine + Magnesium Salicylate
    • Acetaminophen + Diphenhydramine
    • Aspirin + Butalbital + Caffeine
    • Codeine + Acetaminophen
    • Codeine + Acetaminophen + Butalbital + Caffeine
    • Codeine + Aspirin + Butalbital + Caffeine
    • Dihydrocodeine + Acetaminophen + Caffeine
    • Hydrocodone + Acetaminophen
    • Hydrocodone + Ibuprofen
    • Ibuprofen + Diphenhydramine
    • Naproxen + Diphenhydramine
    • Oxycodone + Acetaminophen
    • Tramadol + Acetaminophen
  • Antimigraine Agents
    • Almotriptan
    • Dihydroergotamine Nasal
    • Eletriptan
    • Ergotamine
    • Ergotamine + Caffeine
    • Frovatriptan
    • Naratriptan
    • Rizatriptan
    • Sumatriptan Injection
    • Sumatriptan + Naproxen
    • Zolmitriptan
  • Cox-2 Inhibitors (Celecoxib)
  • Acetaminophen and Miscellaneous Analgesics
    • Acetaminophen
    • Ziconotide
  • Narcotic Analgesics
    • Alfentanil
    • Buprenorphine
    • Butorphanol (Injection)
    • Codeine
    • Fentanyl
    • Hydrocodone
    • Hydromorphone
    • Levorphanol
    • Meperidine
    • Methadone
    • Morphine
    • Nalbuphine
    • Oxycodone
    • Oxymorphone
    • Tramadol
    • Tapentadol
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • More COX-1 selective
      • Flurbiprofen
      • Ketorolac (nasal)
      • Ketoprofen
      • Tolmetin
      • Relatively nonselective
      • Ibuprofen
      • Naproxen
    • Less than 50-fold COX-2 selective
      • Indomethacin
      • Sulindac
      • Piroxicam
      • Mefenamic acid
      • Meloxicam
      • Diclofenac
      • Celecoxib
      • Etodolac
    • Salicylates
      • Aspirin
      • Diflunisal
      • Magnesium salicylate
      • Salsalate
    • CGRP inhibitors
      • Erenumab
      • Galcanezumab
      • Fremanezumab
      • Rimegepant
      • Ubrogepant
      • Atogepant
      • Eptinezumab
      • Zavegepant
  • By Indication (Revenue, USD Bn, 2021 - 2033)
  • Migraine
    • Chronic Migraine
    • Migraine Prevention
  • Headache and Cluster Headaches
  • Allergic Rhinitis
  • Anxiety
  • Back Pain
  • Cold Symptoms
  • Fever
  • Hangover
  • Influenza
  • Insomnia
  • Muscle Pain
  • Osteoarthritis
  • Pain
  • Pain/Fever
  • Period Pain
  • Postoperative Pain
  • Premenstrual Dysphoric Disorder
  • Premenstrual Syndrome
  • Rheumatoid Arthritis
  • Sinusitis
  • Ankylosing Spondylitis
  • Chronic Pain
  • Familial Adenomatous Polyposis
  • High Blood Pressure
  • Juvenile Rheumatoid Arthritis
  • Spondylarthritis
  • Chiari Malformation
  • Eustachian Tube Dysfunction
  • Neck Pain
  • Plantar Fasciitis
  • Sciatica
  • Transverse Myelitis
  • Cough
  • Opioid Use Disorder
  • Aseptic Necrosis
  • Bartter Syndrome
  • Bursitis
  • Chronic Myofascial Pain
  • Costochondritis
  • Diffuse Idiopathic Skeletal Hyperostosis
  • Dysautonomia
  • Frozen Shoulder
  • Gout, Acute
  • Inflammatory Conditions
  • NSAID-Induced Ulcer Prophylaxis
  • Patent Ductus Arteriosus
  • Polyarticular Juvenile Idiopathic Arthritis
  • Polymyalgia Rheumatica
  • Radiculopathy
  • Spondylolisthesis
  • Temporomandibular Joint Disorder
  • Tendonitis
  • Toothache
  • Anesthetic Adjunct
  • Breakthrough Pain
  • Diabetic Peripheral Neuropathy
  • Diarrhea
  • Labor Pain
  • Light Sedation
  • Neonatal Abstinence Syndrome
  • Opiate Dependence - Induction
  • Opiate Dependence - Maintenance
  • Opiate Withdrawal
  • Sedation
  • Angina
  • Angina Pectoris Prophylaxis
  • Antiphospholipid Syndrome
  • Gas
  • Heart Attack
  • Indigestion
  • Ischemic Stroke
  • Ischemic Stroke, Prophylaxis
  • Kawasaki Disease
  • Lupus
  • Myocardial Infarction, Prophylaxis
  • Niacin Flush
  • Prevention of Thromboembolism in Atrial Fibrillation
  • Prosthetic Heart Valves - Thrombosis Prophylaxis
  • Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis
  • Revascularization Procedures, Prophylaxis
  • Rheumatic Fever
  • Thromboembolic Stroke Prophylaxis
  • Transient Ischemic Attack
  • Others
  • By Dosage Form (Revenue, USD Bn, 2021 - 2033)
  • Tablet
  • Capsule
  • Injectable
  • Patches
  • Roll On
  • Spray
  • Creams, Gels and Ointments
  • Others (Suppository, Nasal etc.)
  • By Drug Composition (Revenue, USD Bn, 2021 - 2033)
  • Single
  • Combination
  • By Availability (Revenue, USD Bn, 2021 - 2033)
  • OTC
  • Rx
  • By Type (Revenue, USD Bn, 2021 - 2033)
  • Branded
  • Generics
  • By Gender (Revenue, USD Bn, 2021 - 2033)
  • Male
  • Female
  • By Age Group (Revenue, USD Bn, 2021 - 2033)
  • Pedatric/Infant
  • Children
  • Adult
  • Geriatrics
  • By Route of Administration (Revenue, USD Bn, 2021 - 2033)
  • Oral/Enteral
  • Parenteral
  • Topical (Including Patches)
  • Others (Rectal, etc.)
  • By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Merck & Co., Inc.
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Hikma Pharmaceuticals PLC
  • Reddy's Laboratories Ltd.
  • Fresenius Kabi AG
  • Aurobindo Pharma
  • Bausch Health Companies Inc.
  • Amneal Pharmaceuticals LLC.
  • Apotex Inc.
  • Eli Lilly and Company
  • Cipla Inc.
  • Lupin

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Indication
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Drug Composition
    • Market Snapshot, By Availability
    • Market Snapshot, By Type
    • Market Snapshot, By Gender
    • Market Snapshot, By Age Group
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Analgesics Market, By Drug Class, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Analgesic Combinations (includes Narcotic Analgesic Combinations)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Acetaminophen + Aspirin
      • Acetaminophen + Aspirin + Caffeine
      • Acetaminophen + Butalbital
      • Acetaminophen + Butalbital + Caffeine
      • Acetaminophen + Caffeine
      • Acetaminophen +Caffeine + Isometheptene Muscat
      • Acetaminophen + Caffeine + Magnesium Salicylate
      • Acetaminophen + Diphenhydramine
      • Aspirin + Butalbital + Caffeine
      • Codeine + Acetaminophen
      • Codeine + Acetaminophen + Butalbital + Caffeine
      • Codeine + Aspirin + Butalbital + Caffeine
      • Dihydrocodeine + Acetaminophen + Caffeine
      • Hydrocodone + Acetaminophen
      • Hydrocodone + Ibuprofen
      • Ibuprofen + Diphenhydramine
      • Naproxen + Diphenhydramine
      • Oxycodone + Acetaminophen
      • Tramadol + Acetaminophen
  • Antimigraine Agents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Almotriptan
      • Dihydroergotamine Nasal
      • Eletriptan
      • Ergotamine
      • Ergotamine + Caffeine
      • Frovatriptan
      • Naratriptan
      • Rizatriptan
      • Sumatriptan Injection
      • Sumatriptan + Naproxen
      • Zolmitriptan
  • Compound Inhibitors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Acetaminophen and Miscellaneous Analgesics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Acetaminophen
      • Ziconotide
  • Narcotic Analgesics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Alfentanil
      • Buprenorphine
      • Butorphanol (Injection)
      • Codeine
      • Fentanyl
      • Hydrocodone
      • Hydromorphone
      • Levorphanol
      • Meperidine
      • Methadone
      • Morphine
      • Nalbuphine
      • Oxycodone
      • Oxymorphone
      • Tramadol
      • Tapentadol
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Codeine More COX-1 selective
        • Flurbiprofen
        • Ketorolac (nasal)
        • Ketoprofen
        • Tolmetin
        • Relatively nonselective
        • Ibuprofen
        • Naproxen
      • Less than 50-fold COX-2 selective
        • Indomethacin
        • Sulindac
        • Piroxicam
        • Mefenamic acid
        • Meloxicam
        • Diclofenac
        • Celecoxib
        • Etodolac
      • Salicylates
        • Aspirin
        • Diflunisal
        • Magnesium salicylate
        • Salsalate
      • CGRP inhibitors
        • Erenumab
        • Galcanezumab
        • Fremanezumab
        • Rimegepant
        • Ubrogepant
        • Atogepant
        • Eptinezumab
        • Zavegepant

5. Global Analgesics Market, By Indication, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Migraine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
      • Chronic Migraine
      • Migraine Prevention
  • Headache and Cluster Headaches
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Allergic Rhinitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Anxiety
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Back Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cold Symptoms
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Fever
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Hangover
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Influenza
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Insomnia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Muscle Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Osteoarthritis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Pain/Fever
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Period Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Postoperative Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Premenstrual Dysphoric Disorder
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Premenstrual Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Rheumatoid Arthritis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Sinusitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ankylosing Spondylitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Chronic Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Familial Adenomatous Polyposis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • High Blood pressure
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Juvenile Rheumatoid Arthritis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Spondylarthritis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Chiari Malformation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Eustachian Tube Dysfunction
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Neck Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Plantar Fasciitic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Sciatica
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Transverse Myelitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cough
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Opioid Use Disorder
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Aseptic Necrosis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Bartter Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Bursitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Chronic Myofacial Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Costochondritis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Diffuse Idiopathic Skeletal Hyperostosis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Dysautonomia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Frozen Shoulder
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Gout, Acute
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Inflammatory Conditions
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • NSAID-Induced Ulcer Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Patent Ductus Arteriosus
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Polymyalgia Rheumatica
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Radiculopathy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Spondylolisthesis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Temporomandibular Joint Disorder
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Tendonitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Toothache
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Aesthetic Adjunct
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Breakthrough Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Diabetic Peripheral Neuropathy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Diarrhea
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Labor Pain
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Light Sedation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Neonatal Abstinence Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Opiate Dependence - Induction
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Opiate Dependence - Maintenance
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Opiate Withdrawal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Sediation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Angina
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Angina Pectoris Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Antiphospholipid Syndrome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Gas
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Heart Attack
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Indigestion
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ischemic Stroke
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ischemic Stroke, Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Niacin Flush
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Myocardial Infraction, Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Niacin Flush
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Prevention of Thromboesmbolism in Atrial Fibrillation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Prosthetic Heart Valves- Thrombosis Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Revascularization Procedure, Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Rheumatic Fever
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Thromboembolic Stroke Prophylaxis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Transient Ischemic Attack
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Analgesics Market, By Dosage Form, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Tablet
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Capsules
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Injectable
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Patches
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Roll On
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Spray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Creams, Gels, and Ointments
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others (Suppository, Nasal etc)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Analgesics Market, By Drug Composition, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Single
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Combination
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Analgesics Market, By Availability, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • OTC
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Rx
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Analgesics Market, By Type, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Branded
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Generics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

10. Global Analgesics Market, By Gender, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Male
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Female
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

11. Global Analgesics Market, By Age Group, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pedatric/Infant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Children
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Adult
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Geriatrics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

12. Global Analgesics Market, By Distribution Channel, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

13. Global Analgesics Market, By Age Group, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pedatric/Infant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Children
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Adult
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

14. Global Analgesics Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

15. Competitive Landscape

  • Company Profiles
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mylan N.V.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson Private Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hikma Pharmaceuticals PLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dr. Reddy's Laboratories Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fresenius Kabi AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aurobindo Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bausch Health Companies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Amneal Pharmaceuticals LLC.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Apotex Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cipla Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lupin
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

16. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

17. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact